Stay updated on Apatinib Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Apatinib Plus Pembrolizumab Clinical Trial page.
Latest updates to the Apatinib Plus Pembrolizumab Clinical Trial page
- Check3 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference0.3%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check39 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the location details.SummaryDifference3%
- Check53 days agoChange DetectedSeveral key resources and links related to rare diseases and clinical studies have been removed, including important government and medical websites, which may impact access to critical information.SummaryDifference4%
- Check61 days agoChange DetectedNew resources have been added, including links to rare disease information, drug information, and government health websites, which may enhance access to critical health-related data.SummaryDifference0.4%
- Check68 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference4%
Stay in the know with updates to Apatinib Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Apatinib Plus Pembrolizumab Clinical Trial page.